Pharmaceutical Product Monograph: Orligal Capsules (Orlistat 120 mg)
In the pharmaceutical industry, Orligal is a high-potency Lipase Inhibitor brand, technically identical in its active ingredient to Orlicure or the innovator brand Xenical. As a pharmacist and manufacturer at Healthy Life Pharma, I classify this as a “Non-Systemic Anti-Obesity Agent.”
Orligal is manufactured by Hab Pharma, which has a significant presence in Mumbai and Dehradun. For Healthy Inc, this represents a prime example of a successful Indian pharmaceutical export in the weight management category for 2026.
Therapeutic Profile: Primary Indications
Orligal 120 mg is used for the long-term management of obesity in conjunction with a low-calorie, low-fat diet.
| Indication | Clinical Context | Technical Rationale |
| Obesity Management | BMI $\ge 30\text{ kg/m}^2$ | Blocks the absorption of a significant portion of dietary fats to reduce overall calorie intake. |
| Comorbid Weight Control | BMI $\ge 27\text{ kg/m}^2$ | Used for overweight patients with risk factors like Type 2 Diabetes, Hypertension, or Dyslipidemia. |
| Weight Maintenance | Chronic Use | Prevents the regain of lost weight by limiting the body’s capacity to process new dietary fats. |
Mechanism: The “Fat Blockade” Strategy
Orligal acts as a “Gatekeeper” in the gastrointestinal tract:
Enzyme Inhibition: The active ingredient, Orlistat, binds to the active sites of Gastric and Pancreatic Lipases.
Prevention of Breakdown: These inhibited enzymes are technically unable to hydrolyze triglycerides (fats) into absorbable fatty acids.
The 30% Rule: Approximately 30% of the fat consumed in a meal remains undigested.
Excretion: This unabsorbed fat is not stored in the body; instead, it is eliminated through the stool.
The Pharmacist’s “Technical Warning”
The “Fat-Soluble” Deficit: Because Orligal prevents fat absorption, it technically hinders the uptake of Vitamins A, D, E, and K. Patients should take a daily multivitamin (like your 4G Softgels) at least 2 hours before or after the Orligal dose.
The “Oily” Side Effect: If a patient consumes a very high-fat meal while taking Orligal, the excess undigested fat can cause “oily spotting,” urgency, or fatty stools. This is technically a “dietary feedback” mechanism—it encourages the patient to stick to a low-fat diet.
Timing: One capsule should be taken with each main meal (during or up to 1 hour after eating). If a meal is missed or contains zero fat, the dose must be skipped.
The Manufacturer’s Perspective: Technical & Export
From the CEO’s desk at Healthy Life Pharma / Healthy Inc:
Market Synergy: In your digital marketplace, Orligal (Hab Pharma) is a strong competitor to other Orlistat brands. Highlighting its WHO-GMP manufacturing origin is a key 2026 technical USP for international B2B buyers.
B2B Packaging: Orligal typically comes in larger pack sizes (e.g., 4 x 21 capsules), which is technically ideal for the “3-meal-a-day” dosing schedule, ensuring a 28-day supply per box.
Digital Strategy: Position this under your “Lifestyle & Wellness” category. Use keywords like “Orligal 120mg exporter Mumbai,” “Hab Pharma Orlistat supplier India,” and “B2B weight loss medication 2026.”
Stability: Ensure your export dossiers note that Orlistat is sensitive to heat ($>25\text{°C}$). At Healthy Inc, our controlled-temperature logistics are what define our technical superiority in exporting such molecules.